BioStem Technologies Inc.
Organization details
- Legal name
- BioStem Technologies Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Florida
- Headquarters city
- Pompano Beach
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BSEM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001658678
- EIN
- 27-0400416
Board of directors
-
Hannaway Rayna Lesser · DirectorSince 2026
-
Jason Matuszewski · Director · Chief Executive OfficerSince 2026
-
Jodi Ungrodt · DirectorSince 2026
-
Kenneth Howard Warrington Jr. · DirectorSince 2026
-
Mark A. Glickman · DirectorSince 2026
-
Steven D. Sonenreich · DirectorSince 2026
-
Vurst Andrew Smith-Van · Director · Chief Operating OfficerSince 2026
Chief executives
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
MetaVia Inc. Same sectorvia Mark A. Glickman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 9, 2026 | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | Option exercise | +970 | — | — |
| Nov 1, 2026 | HASSETT BARRY Officer (Chief Commercial Officer) | Option exercise | +253 | — | — |
| Oct 7, 2026 | Jason Matuszewski Director, Officer (Chief Executive Officer), 10% owner | Option exercise | +250,000 | $2.00 | $500,000 |
| Oct 7, 2026 | Vurst Andrew Smith-Van Director, Officer (Chief Operating Officer), 10% owner | Option exercise | +250,000 | $2.00 | $500,000 |
| Sep 17, 2026 | Vurst Andrew Smith-Van Director, Officer (Chief Operating Officer), 10% owner | Option exercise | +9,574 | — | — |
| Sep 17, 2026 | Jason Matuszewski Director, Officer (Chief Executive Officer), 10% owner | Option exercise | +16,650 | — | — |
| Sep 15, 2026 | FORTUNATO MICHAEL A Officer (Chief Accounting Officer) | Option exercise | +4,234 | — | — |
| Sep 15, 2026 | Kenneth Howard Warrington Jr. Director | Option exercise | +1,694 | — | — |
| Sep 15, 2026 | Vurst Andrew Smith-Van Director, Officer (Chief Operating Officer), 10% owner | Option exercise | +7,622 | — | — |
| Sep 15, 2026 | POE BRANDON Officer (Chief Financial Officer) | Option exercise | +1,694 | — | — |
| Sep 15, 2026 | Jason Matuszewski Director, Officer (Chief Executive Officer), 10% owner | Option exercise | +8,469 | — | — |
| Sep 9, 2026 | HASSETT BARRY Officer (Chief Commercial Officer) | Option exercise | +500 | — | — |
| Aug 27, 2026 | Mark A. Glickman Director | Option exercise | +7,671 | — | — |
| Aug 27, 2026 | Hannaway Rayna Lesser Director | Option exercise | +7,671 | — | — |
| Aug 27, 2026 | Kenneth Howard Warrington Jr. Director | Option exercise | +5,094 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about BioStem Technologies Inc.
Who is the CEO of BioStem Technologies Inc.?
Jason Matuszewski has been BioStem Technologies Inc.'s Chief Executive Officer since August 2026.
How many directors are on BioStem Technologies Inc.'s board?
BioStem Technologies Inc.'s board has 7 directors: Hannaway Rayna Lesser, Jason Matuszewski, Jodi Ungrodt, Kenneth Howard Warrington Jr., Mark A. Glickman, Steven D. Sonenreich and Vurst Andrew Smith-Van.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="biostem-technologies-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.